These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

541 related items for PubMed ID: 18700559

  • 1. [Blood pressure goal and choice of antihypertensive treatment in patients with mild hypertensive cardiovascular disease].
    Narumi H, Takano H, Komuro I.
    Nihon Rinsho; 2008 Aug; 66(8):1566-73. PubMed ID: 18700559
    [Abstract] [Full Text] [Related]

  • 2. [Usefulness of early-stage intervention in mild hypertension: evidence from large-scale clinical trials].
    Hashimoto T, Ohkubo T, Imai Y.
    Nihon Rinsho; 2008 Aug; 66(8):1464-70. PubMed ID: 18700543
    [Abstract] [Full Text] [Related]

  • 3. ESH-ESC guidelines for the management of hypertension.
    Erdine S, Ari O, Zanchetti A, Cifkova R, Fagard R, Kjeldsen S, Mancia G, Poulter N, Rahn KH, Rodicio JL, Ruilope LM, Staessen J, van Zwieten P, Waeber B, Williams B.
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [Abstract] [Full Text] [Related]

  • 4. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
    Khan NA, McAlister FA, Campbell NR, Feldman RD, Rabkin S, Mahon J, Lewanczuk R, Zarnke KB, Hemmelgarn B, Lebel M, Levine M, Herbert C, Canadian Hypertension Education Program.
    Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
    [Abstract] [Full Text] [Related]

  • 5. [Regression of left ventricular hypertrophy in hypertensive patients].
    Bosa Ojeda F, García González M, Domínguez Rodríguez A, Barragán Acea A, Miralles Ibarra JM, Lacalzada Almeida J, de Armas Trujillo D.
    Rev Esp Cardiol; 1997 Jan; 50 Suppl 4():74-6. PubMed ID: 9411592
    [Abstract] [Full Text] [Related]

  • 6. Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trials.
    Moser M, Hebert PR.
    J Am Coll Cardiol; 1996 Apr; 27(5):1214-8. PubMed ID: 8609345
    [Abstract] [Full Text] [Related]

  • 7. Left ventricular hypertrophy: how to influence an important risk factor in hypertension.
    Agabiti-Rosei E, Muiesan ML.
    J Hypertens Suppl; 1998 Jan; 16(1):S53-8. PubMed ID: 9534098
    [Abstract] [Full Text] [Related]

  • 8. Choice of antihypertensive drug in the diabetic patient.
    Ong HT, Cheah JS.
    MedGenMed; 2005 May 04; 7(2):74. PubMed ID: 16369452
    [Abstract] [Full Text] [Related]

  • 9. Left ventricular hypertrophy and clinical outcomes in hypertensive patients.
    Ruilope LM, Schmieder RE.
    Am J Hypertens; 2008 May 04; 21(5):500-8. PubMed ID: 18437140
    [Abstract] [Full Text] [Related]

  • 10. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
    Oparil S, Bakir SE.
    Drugs; 2000 May 04; 59 Spec No 2():25-37. PubMed ID: 11002856
    [Abstract] [Full Text] [Related]

  • 11. [The primary and secondary prevention of hypertensive cardiopathy].
    Agabiti-Rosei E, Muiesan ML.
    Ital Heart J; 2000 Jun 04; 1 Suppl 2():59-66. PubMed ID: 10905130
    [Abstract] [Full Text] [Related]

  • 12. Prognostic value of changes in the electrocardiographic strain pattern during antihypertensive treatment: the Losartan Intervention for End-Point Reduction in Hypertension Study (LIFE).
    Okin PM, Oikarinen L, Viitasalo M, Toivonen L, Kjeldsen SE, Nieminen MS, Edelman JM, Dahlöf B, Devereux RB, LIFE Study Investigators.
    Circulation; 2009 Apr 14; 119(14):1883-91. PubMed ID: 19332468
    [Abstract] [Full Text] [Related]

  • 13. Hypertensive heart disease.
    Diamond JA, Phillips RA.
    Hypertens Res; 2005 Mar 14; 28(3):191-202. PubMed ID: 16097361
    [Abstract] [Full Text] [Related]

  • 14. Prognostic significance of left ventricular diastolic dysfunction in patients with left ventricular hypertrophy and systemic hypertension (the LIFE Study).
    Wachtell K, Palmieri V, Gerdts E, Bella JN, Aurigemma GP, Papademetriou V, Dahlöf B, Aalto T, Ibsen H, Rokkedal JE, Devereux RB.
    Am J Cardiol; 2010 Oct 01; 106(7):999-1005. PubMed ID: 20854964
    [Abstract] [Full Text] [Related]

  • 15. From left ventricular hypertrophy to congestive heart failure: management of hypertensive heart disease.
    Gradman AH, Alfayoumi F.
    Prog Cardiovasc Dis; 2006 Oct 01; 48(5):326-41. PubMed ID: 16627048
    [Abstract] [Full Text] [Related]

  • 16. [Antihypertensive therapy in the elderly: results of large trials].
    Leonetti G, Cuspidi C, Facchini M.
    Ital Heart J Suppl; 2001 Nov 01; 2(11):1161-9. PubMed ID: 11775407
    [Abstract] [Full Text] [Related]

  • 17. [Impact of arterial hypertension on the heart].
    Herpin D.
    Rev Prat; 1999 Mar 01; 49(5):491-4. PubMed ID: 10358398
    [Abstract] [Full Text] [Related]

  • 18. Treatment of hypertension in chronic kidney disease.
    Toto RD.
    Semin Nephrol; 2005 Nov 01; 25(6):435-9. PubMed ID: 16298269
    [Abstract] [Full Text] [Related]

  • 19. [Retrospective studies and prospects of therapy for hypertension].
    Maisch B, Brilla C, Kruse T, Noll B, Bethge C.
    Herz; 1995 Dec 01; 20(6):370-89. PubMed ID: 8582697
    [Abstract] [Full Text] [Related]

  • 20. Management of hypertension in peripheral arterial disease: does the choice of drugs matter?
    Singer DR, Kite A.
    Eur J Vasc Endovasc Surg; 2008 Jun 01; 35(6):701-8. PubMed ID: 18375152
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.